نتایج جستجو برای: metformin hyperinsulinemia

تعداد نتایج: 16815  

Journal: :Prilozi 2006
B Krstevska Ch Dimitrovski G Pemovska S Misevska Z Dimova S Simeonova I Ahmeti

OBJECTIVE To evaluate the therapeutic effect of metformin on the clinical features, hormonal and metabolic profile in obese women with a hyperinsulinemic polycystic ovary syndrome (PCOS). MATERIAL AND METHODS We analyzed 25 women with PCOS, mean age 27.28+/-7.85 years, BMI 34.42+/-6.61 kg/m2, FerrimanGallwey (F/G) score 17.43+/-5.45 and duration of menstrual cycle 79.2 +/- 54.5 days. Basal ho...

2013
Daniela Romualdi Simona De Cicco Donatella Gagliano Matteo Busacca Giuseppe Campagna Antonio Lanzone Maurizio Guido

OBJECTIVE Metformin has been reported to reduce the risk of gestational diabetes (GD) in women with polycystic ovarian syndrome (PCOS). However, little is known about the mechanisms of action of this drug during pregnancy. In the attempt to fill this gap, we performed a prospective longitudinal study providing a detailed examination of glucose and insulin metabolism in pregnant women with PCOS ...

Journal: :Cell cycle 2008
Vladimir N Anisimov Lev M Berstein Peter A Egormin Tatiana S Piskunova Irina G Popovich Mark A Zabezhinski Margarita L Tyndyk Maria V Yurova Irina G Kovalenko Tatiana E Poroshina Anna V Semenchenko

Studies in mammals have led to the suggestion that hyperglycemia and hyperinsulinemia are important factors both in aging and in the development of cancer. It is possible that the life-prolonging effects of calorie restriction are due to decreasing IGF-1 levels. A search of pharmacological modulators of insulin/IGF-1 signaling pathway (which resemble effects of life span extending mutations or ...

2016
Rosa Lauretta Giulia Lanzolla Patrizia Vici Luciano Mariani Costanzo Moretti Marialuisa Appetecchia

Preclinical, early phase clinical trials and epidemiological evidence support the potential role of insulin-sensitizers in cancer prevention and treatment. Insulin-sensitizers improve the metabolic and hormonal profile in PCOS patients and may also act as anticancer agents, especially in cancers associated with hyperinsulinemia and oestrogen dependent cancers. Several lines of evidence support ...

Journal: :Saudi medical journal 2007
Hussein S Qublan Eleni K Yannakoula Mohamad A Al-Qudah Fahmi I El-Uri

OBJECTIVE To compare the clinical results and reproductive outcome in obese women with polycystic ovary syndrome (PCOS) following dietary intervention or treatment with metformin. METHODS Forty-six patients with PCOS were studied prospectively in Prince Rashed Hospital, Irbid, Jordan, between January 2003 and April 2005. The women were randomly divided into 2 groups: Group 1 (n=24) was prescr...

2011
David H Geller Danièle Pacaud Catherine M Gordon Madhusmita Misra

PCOS, a heterogeneous disorder characterized by cystic ovarian morphology, androgen excess, and/or irregular periods, emerges during or shortly after puberty. Peri- and post-pubertal obesity, insulin resistance and consequent hyperinsulinemia are highly prevalent co-morbidities of PCOS and promote an ongoing state of excess androgen. Given the relationship of insulin to androgen excess, reducti...

Journal: :Journal of laparoendoscopic & advanced surgical techniques. Part A 2008
Nelson Wolosker Guilherme Yazbek Augusto Ishy José Ribas M de Campos Paulo Kauffman Pedro Puech-Leão

PURPOSE We compared the results from a video-assisted thoracoscopic sympathectomy (VTS) at the T4 denervation level with those from a VTS at the T3 level for the treatment of palmar hyperhydrosis (PH). METHODS Seventy patients with PH were prospectively followed for VTS at the T3 or T4 denervation levels for 6 months. The end points of this study were: absence of PH, compensatory hyperhydrosi...

2016
Denice S. Feig Kellie Murphy Elizabeth Asztalos George Tomlinson Johanna Sanchez Bernard Zinman Arne Ohlsson Edmond A. Ryan I. George Fantus Anthony B. Armson Lorraine L. Lipscombe Jon F.R. Barrett George Carson Suzanne Williams Sheila Kelly Heather Clark Diane Donat Shital Gandhi Barbara Cleave Michele Strom Lois Donovan Carolyn Oldford Catherine Young Brenda Galway Minnie Parsons Ariane Godbout Michele Mahone Florence Weber Marie-Josee Bedard Bi Lan Wo Sylvie Daigle Amir Hanna Maria Wolfs Leanne De Souza Robyn Houlden Adriana Breen Tina Kader Luca Cefis Erin Keely Josee Champagne Jennifer Klinke Julie Lee Peter Subrt Francina Carr Sharon Young Sarah Kwong Heather Rylance Helene Long Julie Lambert Julia Lowe Anna Rogowsky Susan Jackson Sora Ludwig Laurie Slater Lori Berard David McIntyre Anne Tremellen Ruth McManus Sara Meltzer Natasha Garfield Shari Segal David Miller Karen Coles Carol Fergusson Jill Newstead-Angel Judy Brandt Thomas Ransom Darlene Baxendale Evelyne Rey Diane Francoeur Sophie Perreault Dory Sample David Thompson Sharon Thompson John S Weisnagel Camile Lambert Valerie-Eve Julien Marie-Christine Dube Louise Rheaume Afshan Zahedi Grace Lee Krystyna Szwiega Asma Qureshi Siobhan Tobin

BACKGROUND The incidence of type 2 diabetes in pregnancy is rising and rates of serious adverse maternal and fetal outcomes remain high. Metformin is a biguanide that is used as first-line treatment for non-pregnant patients with type 2 diabetes. We hypothesize that metformin use in pregnancy, as an adjunct to insulin, will decrease adverse outcomes by reducing maternal hyperglycemia, maternal ...

2014
Harriette R. Mogul Ruth Freeman Khoa Nguyen Michael Frey Lee-Ann Klein Sheila Jozak Karen Tanenbaum Yiqing Song

RATIONALE Progressive midlife weight gain is associated with multiple adverse health outcomes and may represent an early manifestation of insulin resistance in a distinct subset of women. Emerging data implicate hyperinsulinema as a proximate cause of weight gain and support strategies that attenuate insulin secretion. OBJECTIVE To assess a previously reported novel hypocaloric carbohydrate m...

Journal: : 2022

Metformin in its protonated form as metformin hydrochloride is used worldwide an advanced antidiabetic drug for type 2 diabetes. Hyperinsulinemia and insulin resistance of cells are the main causes this disease. For patients with diabetes, (MET) works by improving cell sensitivity to insulin.
 It has been shown that methyl orange (MO) forms ionic associate can be isolated solid suitable cr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید